Antisense Therapeutics Limited Dividend 2022

Antisense Therapeutics Limited (ANP) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly. ANP has three products including ATL1102 injection for Multiple Sclerosis, ATL1103 injection for growth & sight disorders, and ATL1102 inhaled for asthma.

Antisense Therapeutics Limited operators in Health Care sector and under industry of Pharmaceuticals. The company website is:

You can also check out dividend history for similar stocks in the same sector as follows:

ANP Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found